Zurich Cantonal Bank
BSX icon

Zurich Cantonal Bank’s Boston Scientific BSX Stock Holding History

Zurich Cantonal Bank’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112M Buy
1,791,149
+60,784
+4% +$4.86M 0.24% 75
2025
Q4 		$165M Sell
1,730,365
-135,917
-7% -$13.3M 0.36% 35
2025
Q3 		$182M Buy
1,866,282
+50,938
+3% +$5.28M 0.42% 31
2025
Q2 		$195M Buy
1,815,344
+495,346
+38% +$50.1M 0.48% 28
2025
Q1 		$133M Buy
1,319,998
+27,572
+2% +$2.78M 0.38% 41
2024
Q4 		$115M Buy
1,292,426
+20,726
+2% +$1.82M 0.33% 43
2024
Q3 		$107M Buy
1,271,700
+561,715
+79% +$44.3M 0.32% 52
2024
Q2 		$54.7M Buy
709,985
+265,864
+60% +$19.5M 0.18% 95
2024
Q1 		$30.4M Buy
444,121
+149,873
+51% +$9.64M 0.11% 168
2023
Q4 		$17M Sell
294,248
-270,264
-48% -$14.4M 0.07% 275
2023
Q3 		$29.8M Buy
564,512
+50,449
+10% +$2.65M 0.13% 136
2023
Q2 		$27.8M Buy
514,063
+89,431
+21% +$4.67M 0.12% 144
2023
Q1 		$21.2M Buy
424,632
+19,914
+5% +$939K 0.1% 182
2022
Q4 		$18.7M Buy
404,718
+43,852
+12% +$1.9M 0.1% 197
2022
Q3 		$14M Buy
360,866
+17,970
+5% +$721K 0.08% 225
2022
Q2 		$12.8M Buy
342,896
+14,505
+4% +$590K 0.07% 257
2022
Q1 		$14.5M Buy
328,391
+21,550
+7% +$934K 0.07% 255
2021
Q4 		$13M Sell
306,841
-32,255
-10% -$1.36M 0.06% 279
2021
Q3 		$14.7M Sell
339,096
-20,355
-6% -$901K 0.08% 233
2021
Q2 		$15.4M Sell
359,451
-1,929
-0.5% -$81.2K 0.09% 228
2021
Q1 		$14M Buy
361,380
+9,820
+3% +$372K 0.08% 227
2020
Q4 		$12.6M Buy
351,560
+14,344
+4% +$517K 0.08% 242
2020
Q3 		$12.9M Buy
337,216
+41,336
+14% +$1.59M 0.09% 200
2020
Q2 		$10.4M Sell
295,880
-63,471
-18% -$2.29M 0.09% 219
2020
Q1 		$11.7M Buy
359,351
+43,473
+14% +$1.7M 0.11% 184
2019
Q4 		$14.3M Sell
315,878
-12,802
-4% -$536K 0.11% 205
2019
Q3 		$13.4M Sell
328,680
-173,677
-35% -$7.36M 0.11% 203
2019
Q2 		$21.6M Buy
502,357
+31,461
+7% +$1.21M 0.18% 115
2019
Q1 		$18.1M Buy
470,896
+20,353
+5% +$777K 0.16% 139
2018
Q4 		$15.9M Buy
450,543
+102,924
+30% +$3.73M 0.16% 147
2018
Q3 		$13.4M Buy
347,619
+16,848
+5% +$588K 0.11% 217
2018
Q2 		$10.8M Buy
330,771
+1,471
+0.4% +$44.4K 0.1% 256
2018
Q1 		$9M Buy
329,300
+6,077
+2% +$165K 0.08% 296
2017
Q4 		$8.01M Sell
323,223
-504
-0.2% -$13.9K 0.07% 319
2017
Q3 		$9.44M Sell
323,727
-6,977
-2% -$193K 0.09% 275
2017
Q2 		$9.17M Sell
330,704
-56,692
-15% -$1.5M 0.09% 256
2017
Q1 		$9.63M Sell
387,396
-16,380
-4% -$398K 0.1% 239
2016
Q4 		$8.73M Sell
403,776
-209,513
-34% -$4.57M 0.09% 238
2016
Q3 		$14.6M Buy
613,289
+75,768
+14% +$1.81M 0.15% 146
2016
Q2 		$12.6M Sell
537,521
-15,985
-3% -$346K 0.16% 136
2016
Q1 		$10.4M Sell
553,506
-13,636
-2% -$240K 0.13% 158
2015
Q4 		$10.5M Buy
567,142
+167,117
+42% +$2.99M 0.13% 159
2015
Q3 		$6.56M Buy
400,025
+3,266
+0.8% +$55.8K 0.09% 201
2015
Q2 		$7.02M Buy
396,759
+71,816
+22% +$1.28M 0.1% 206
2015
Q1 		$5.77M Buy
324,943
+133,007
+69% +$2.1M 0.08% 243
2014
Q4 		$2.54M Buy
191,936
+62,759
+49% +$802K 0.08% 309
2014
Q3 		$1.53M Sell
129,177
-221,062
-63% -$2.78M 0.05% 428
2014
Q2 		$4.47M Buy
350,239
+9,440
+3% +$123K 0.13% 181
2014
Q1 		$4.61M Sell
340,799
-20,440
-6% -$268K 0.14% 154
2013
Q4 		$4.34M Buy
361,239
+154,584
+75% +$1.83M 0.14% 157
2013
Q3 		$2.43M Buy
206,655
+29,593
+17% +$320K 0.08% 265
2013
Q2 		$1.64M Buy
+177,062
New +$1.5M 0.06% 317

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Zurich Cantonal Bank's BSX Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Boston Scientific (BSX) stake by 3.5% in Q1 2026, buying an estimated $4.86M and bringing the position to 1,791,149 shares worth $112M. The position accounts for 0.24% of the portfolio, ranked #75.

Zurich Cantonal Bank first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $195M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Zurich Cantonal Bank held 1,791,149 shares of Boston Scientific worth $112M as of Q1 2026.
  • Zurich Cantonal Bank bought 60,784 Boston Scientific shares in Q1 2026, an estimated $4.86M.
  • Boston Scientific made up 0.24% of Zurich Cantonal Bank's portfolio in Q1 2026, its #75 holding.
  • Zurich Cantonal Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Zurich Cantonal Bank's Boston Scientific position peaked at $195M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.